KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Blackline (BL) Research & Development (2016 - 2025)

Historic Research & Development for Blackline (BL) over the last 11 years, with Q3 2025 value amounting to $27.3 million.

  • Blackline's Research & Development rose 655.78% to $27.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.6 million, marking a year-over-year increase of 671.46%. This contributed to the annual value of $101.0 million for FY2024, which is 216.46% down from last year.
  • Per Blackline's latest filing, its Research & Development stood at $27.3 million for Q3 2025, which was up 655.78% from $28.0 million recorded in Q2 2025.
  • In the past 5 years, Blackline's Research & Development registered a high of $28.0 million during Q4 2022, and its lowest value of $18.8 million during Q2 2021.
  • Over the past 5 years, Blackline's median Research & Development value was $25.7 million (recorded in 2024), while the average stood at $24.8 million.
  • As far as peak fluctuations go, Blackline's Research & Development skyrocketed by 6151.36% in 2021, and later crashed by 1942.76% in 2023.
  • Blackline's Research & Development (Quarter) stood at $20.7 million in 2021, then surged by 35.3% to $28.0 million in 2022, then fell by 19.43% to $22.6 million in 2023, then rose by 8.9% to $24.6 million in 2024, then rose by 11.16% to $27.3 million in 2025.
  • Its Research & Development stands at $27.3 million for Q3 2025, versus $28.0 million for Q2 2025 and $25.7 million for Q1 2025.